3.0.0
1525
2025-09-10T08:06:41Z
2025-09-10T08:06:41Z
House
H
HR
2025-02-24
119
https://www.congress.gov/bill/119th-congress/house-bill/1525
[Congressional Record Volume 171, Number 36 (Monday, February 24, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. HERN of Oklahoma:H.R. 1525.Congress has the power to enact this legislation pursuantto the following:Article I Section 8[Page H769]
- hsif00
Energy and Commerce Committee
House
Standing
  - Referred To
2025-02-24T17:03:25Z
- 2025-02-24
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2025-02-24
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2025-02-24
Introduced in House
IntroReferral
1000
9
Library of Congress
- H001082
Rep. Hern, Kevin [R-OK-1]
Kevin
Hern
R
OK
1
N
- A000055
Rep. Aderholt, Robert B. [R-AL-4]
Robert
Aderholt
R
AL
B.
4
2025-02-24
True
- F000446
Rep. Feenstra, Randy [R-IA-4]
Randy
Feenstra
R
IA
4
2025-02-24
True
- M001194
Rep. Moolenaar, John R. [R-MI-2]
John
Moolenaar
R
MI
R.
2
2025-02-24
True
- B001307
Rep. Baird, James R. [R-IN-4]
James
Baird
R
IN
R.
4
2025-02-24
True
- W000814
Rep. Weber, Randy K. Sr. [R-TX-14]
Randy
Weber
R
TX
K.
14
2025-02-24
True
- W000806
Rep. Webster, Daniel [R-FL-11]
Daniel
Webster
R
FL
11
2025-02-24
True
- C001120
Rep. Crenshaw, Dan [R-TX-2]
Dan
Crenshaw
R
TX
2
2025-02-24
True
- N000189
Rep. Newhouse, Dan [R-WA-4]
Dan
Newhouse
R
WA
4
2025-02-24
True
- G000590
Rep. Green, Mark E. [R-TN-7]
Mark
Green
R
TN
E.
7
2025-02-24
True
- B000825
Rep. Boebert, Lauren [R-CO-4]
Lauren
Boebert
R
CO
4
2025-02-24
True
- R000609
Rep. Rutherford, John H. [R-FL-5]
John
Rutherford
R
FL
H.
5
2025-02-24
True
- B001295
Rep. Bost, Mike [R-IL-12]
Mike
Bost
R
IL
12
2025-02-24
True
- G000591
Rep. Guest, Michael [R-MS-3]
Michael
Guest
R
MS
3
2025-02-24
True
- S001224
Rep. Self, Keith [R-TX-3]
Keith
Self
R
TX
3
2025-02-24
True
- D000634
Rep. Downing, Troy [R-MT-2]
Troy
Downing
R
MT
2
2025-02-24
True
- M001211
Rep. Miller, Mary E. [R-IL-15]
Mary
Miller
R
IL
E.
15
2025-02-24
True
- D000626
Rep. Davidson, Warren [R-OH-8]
Warren
Davidson
R
OH
8
2025-02-24
True
- R000612
Rep. Rose, John W. [R-TN-6]
John
Rose
R
TN
W.
6
2025-02-24
True
- H001101
Rep. Harrigan, Pat [R-NC-10]
Pat
Harrigan
R
NC
10
2025-02-24
True
- L000578
Rep. LaMalfa, Doug [R-CA-1]
Doug
LaMalfa
R
CA
1
2025-02-24
True
- H001091
Rep. Hinson, Ashley [R-IA-2]
Ashley
Hinson
R
IA
2
2025-05-19
False
- C001118
Rep. Cline, Ben [R-VA-6]
Ben
Cline
R
VA
6
2025-06-04
False
- B001302
Rep. Biggs, Andy [R-AZ-5]
Andy
Biggs
R
AZ
5
2025-09-09
False
Health
- Abortion
2025-07-17T19:13:10Z
- Drug safety, medical device, and laboratory regulation
2025-07-17T19:13:41Z
- Drug therapy
2025-07-17T19:13:19Z
- Government information and archives
2025-07-17T19:13:32Z
- Health information and medical records
2025-07-17T19:13:48Z
- Prescription drugs
2025-07-17T19:13:14Z
Health
2025-03-18T14:22:41Z
00
2025-02-24
Introduced in House
2025-05-14T15:17:58Z
Protecting Life from Chemical Abortions Act
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
The FDA regulates mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.
In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be program-certified in order to dispense mifepristone. The modifications allow certified retail pharmacies to dispense mifepristone pursuant to prescriptions that are written by certified prescribers.
The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.
The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

Protecting Life from Chemical Abortions Act
- Display Title
45

Protecting Life from Chemical Abortions Act
2025-03-17T12:53:30Z
- Short Title(s) as Introduced
101

Protecting Life from Chemical Abortions Act
2025-03-17T12:53:24Z
Introduced in House
IH
- Official Title as Introduced
6

To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.
2025-03-17T12:48:42Z
Introduced in House
IH
- Introduced in House
2025-02-24T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-119hr1525ih/xml/BILLS-119hr1525ih.xml
2025-02-24
Referred to the House Committee on Energy and Commerce.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.